BRAMBILLA, RICCARDO
 Distribuzione geografica
Continente #
NA - Nord America 629
EU - Europa 287
AS - Asia 123
SA - Sud America 17
AF - Africa 3
Totale 1.059
Nazione #
US - Stati Uniti d'America 623
IE - Irlanda 134
IT - Italia 79
SG - Singapore 65
CN - Cina 36
DE - Germania 17
BR - Brasile 14
BE - Belgio 12
CH - Svizzera 11
AT - Austria 9
CA - Canada 6
NL - Olanda 6
AL - Albania 5
HK - Hong Kong 5
FI - Finlandia 4
GB - Regno Unito 3
IN - India 3
JP - Giappone 3
IR - Iran 2
MA - Marocco 2
MY - Malesia 2
PE - Perù 2
SE - Svezia 2
TR - Turchia 2
BG - Bulgaria 1
BO - Bolivia 1
DZ - Algeria 1
ES - Italia 1
ID - Indonesia 1
IQ - Iraq 1
JO - Giordania 1
PK - Pakistan 1
PL - Polonia 1
PT - Portogallo 1
RU - Federazione Russa 1
TH - Thailandia 1
Totale 1.059
Città #
Chandler 203
Dublin 134
Ashburn 46
Boardman 37
Singapore 37
Princeton 31
Lawrence 30
Wilmington 30
Medford 23
Ann Arbor 12
Brussels 12
Milan 12
Nanjing 12
Los Angeles 8
Chicago 7
Padova 7
St. Gallen 7
Barbianello 6
New York 6
Hong Kong 5
Munich 5
Pavia 5
Tirana 5
Guangzhou 4
Helsinki 4
Perugia 4
Seattle 4
Toronto 4
Vienna 4
Beijing 3
Bengaluru 3
Bielefeld 3
Chongqing 3
Des Moines 3
Falls Church 3
Ferrara 3
Florence 3
Limbiate 3
Norwalk 3
Recanati 3
Washington 3
Beugen 2
Cardiff 2
Fairfield 2
Falkenstein 2
Geneva 2
Istanbul 2
Lima 2
Montichiari 2
Nuremberg 2
Piemonte 2
Saccolongo 2
Turin 2
Vado Ligure 2
Vimercate 2
Zhengzhou 2
Amman 1
Ascoli Piceno 1
Atlanta 1
Baghdad 1
Bang Sue 1
Bom Despacho 1
Buffalo 1
Cagliari 1
Camden 1
Cataguases 1
Catanzaro 1
Cinisello Balsamo 1
Conceição do Jacuípe 1
Dallas 1
Fayetteville 1
Fortaleza 1
Frankfurt am Main 1
Geislingen an der Steige 1
Genoa 1
Gorlago 1
Henderson 1
Huzhou 1
Islamabad 1
Jakarta 1
La Paz 1
Lajinha 1
Lanzhou 1
Lincoln 1
Lisbon 1
Lugano 1
Montreal 1
Málaga 1
Nanyang 1
Newark 1
Palermo 1
Patrocínio 1
Porangaba 1
Poá 1
Rabat 1
Raul Soares 1
Rolim de Moura do Guaporé 1
Rome 1
Santa Clara 1
Santana do Seridó 1
Totale 814
Nome #
Neuroprotective peptide 60
Enhancing cognition through pharmacological and environmental interventions: Examples from preclinical models of neurodevelopmental disorders 51
Differential allelic expression of SOS1 and hyperexpression of the activating SOS1 c.755C variant in a Noonan syndrome family 45
Genetic enhancement of Ras-ERK pathway does not aggravate L-DOPA-induced dyskinesia in mice but prevents the decrease induced by lovastatin 43
Therapeutic for treating neuropsychiatric disorders or conditions 41
Severe Intellectual Disability and Enhanced Gamma-Aminobutyric Acidergic Synaptogenesis in a Novel Model of Rare RASopathies 40
Behavioral Methods for the Study of Ras-ERK Pathway in Memory Formation and Consolidation: Passive Avoidance and Object Recognition Tests 39
Regulator of G-Protein Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for l-Dopa-induced dyskinesia 36
Editorial 35
Impairment of cocaine-mediated behaviours in mice by clinically relevant ras-ERK inhibitors 34
Lentiviral Vectors as Research Tools in Neurobiology: Design and Production 34
Dopamine D1 and Glutamate Receptors Co-operate With Brain-Derived Neurotrophic Factor (BDNF) and TrkB to Modulate ERK Signaling in Adult Striatal Slices 33
Neuronal signaling and behavior 32
Viral Vector Approaches in Neurobiology and Brain Diseases”, Neuromethods (Humana Press, Springer) 31
Reduced SNAP-25 increases PSD-95 mobility and impairs spine morphogenesis 30
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease 29
Modulating voltage-gated sodium channels to enhance differentiation and sensitize glioblastoma cells to chemotherapy 28
Increased lipolysis and altered lipid homeostasis protect γ-synuclein-null mutant mice from diet-induced obesity 27
A rational design of α-helix-shaped peptides employing the hydrogen-bond surrogate approach: A modulation strategy for ras-rasgrf1 interaction in neuropsychiatric disorders 27
Anti-Parkinsonian and anti-dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists 26
Understanding cognitive deficits in Parkinson's disease: Lessons from preclinical animal models 26
Molecular and cellular mechanisms of dopamine-mediated behavioral plasticity in the striatum 26
Derangement of ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) and extracellular signal-regulated kinase (ERK) dependent striatal plasticity in L-DOPA-Induced dyskinesia 26
Coordinated Regulation of Synaptic Plasticity at Striatopallidal and Striatonigral Neurons Orchestrates Motor Control 26
Synaptic GluN2B/CaMKII-α signaling induces synapto-nuclear transport of ERK and jacob 26
The Inhibition of RasGRF2, But Not RasGRF1, Alters Cocaine Reward in Mice 25
Blockade of the IL-1R1/TLR4 pathway mediates disease-modification therapeutic effects in a model of acquired epilepsy 25
Differential involvement of Ras-GRF1 and Ras-GRF2 in L-DOPA-induced dyskinesia 24
Role of nucleus accumbens μ opioid receptors in the effects of morphine on ERK1/2 phosphorylation 24
Nicotine self-administration and ERK signaling are altered in RasGRF2 knockout mice 21
Gut-muscle-brain axis: Molecular mechanisms in neurodegenerative disorders and potential therapeutic efficacy of probiotic supplementation coupled with exercise 21
Dissecting the autism-associated 16p11.2 locus identifies multiple drivers in neuroanatomical phenotypes and unveils a male-specific role for the major vault protein 20
Phosphorylation of Parkin at serine 65 is essential for its activation in vivo 19
Pharmacological inhibition of ERK signaling rescues pathophysiology and behavioral phenotype associated with 16p11.2 chromosomal deletion in mice 19
Emerging roles of brain metabolism in cognitive impairment and neuropsychiatric disorders 16
Nuclear ERK1/2 signaling potentiation enhances neuroprotection and cognition via Importinα1/KPNA2 13
Understanding copy number variations through their genes: a molecular view on 16p11.2 deletion and duplication syndromes 11
Endogenous LRRK2 and PINK1 function in a convergent neuroprotective ciliogenesis pathway in the brain 10
Nociceptin/orphanin FQ receptor agonists attenuate L-DOPA-induced dyskinesias 9
Mice with 16p11.2 Deletion and Duplication Show Alterations in Biological Processes Associated with White Matter 5
Totale 1.113
Categoria #
all - tutte 7.740
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.740


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202137 0 0 0 0 0 0 32 5 0 0 0 0
2021/2022133 0 0 5 0 7 2 2 16 15 3 16 67
2022/2023469 44 54 4 53 44 49 0 22 171 2 16 10
2023/2024157 19 10 4 13 25 42 9 5 1 9 5 15
2024/2025317 17 46 22 23 50 39 46 29 45 0 0 0
Totale 1.113